Clinical trial
The Efficacy of Spironolactone in Patients With Resistant Hypertension
NCT00430794 · Sheffield Teaching Hospitals NHS Foundation Trust, Other · Terminated
Key facts
| NCT number | NCT00430794 |
|---|---|
| Title | The Efficacy of Spironolactone in Patients With Resistant Hypertension |
| Official title | A Randomised, Placebo Controlled Trial of the Efficacy of the Addition of Spironolactone to Modern Antihypertensive Treatment Regimens in Patients With Resistant Hypertension |
| Lead sponsor | Sheffield Teaching Hospitals NHS Foundation Trust, Other |
| Collaborators | University of Sheffield |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Spironolactone |
| Enrollment | 40 |
| Start date | Mar 1, 2007 |
| Completion | Dec 1, 2008 |
| First posted | Feb 2, 2007 |
| Last update posted | Dec 6, 2010 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: